GLTO Damora Therapeutics, Inc.: institutional ownership and insider trading
Over the last 12 months insiders bought $253K and sold $30.7K on the open market.
Recent GLTO insider trades
- Sep 25, 2026: Jarrett Jennifer bought 12,500 shares ($253K)
- Jul 6, 2026: Winslow Garrett sold 245 shares ($7.35K)
- Jan 2, 2026: Firmani Lori sold 135 shares ($2.89K)
- Jan 2, 2026: Winslow Garrett sold 255 shares ($5.45K)
5%+ owners
- Fairmount Funds Management LLC: 20.0% (Schedule 13D/A, filed Feb 11, 2026)
- FMR LLC: 15.0% (Schedule 13G, filed Dec 5, 2025)
- Avoro Capital Advisors LLC: 6.3% (Schedule 13G, filed May 15, 2026)
- Venrock Healthcare Capital Partners III, L.P.: 6.0% (Schedule 13G, filed Feb 17, 2026)
- BlackRock, Inc.: 5.1% (Schedule 13G, filed Jul 28, 2026)